From: US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers
Mean ± Stdev
US-DOT
THC
181.296 ± 76.888
DCE-MR
Ktrans
0.133 ± 0.066
k ep
0.482 ± 0.157
SER
1.057 ± 0.063